HLA-C and neoplasm: To do so, we subjected variant peptides encoded by the nsSNVs to binding affinity prediction across diverse classes of HLA alleles, which have been widely used in antigen-MHC binding affinity prediction with high accuracy, for example, the neoantigen prediction from tumor patients.47